I agree that it is doubtful that any trial results will be accepted by the US or other western countries.
If we can get into China and India on good results - WOW.
However, there is nothing in the MOU that stops RCE doing trials anywhere else so RCE can easily do trials in Indonesia and elsewhere.
That can only be a win - win for RCE.
Also, while not being accepted by the regulators if the Indonesian trial results are as positive as we all expect the big pharma companies will certainly take notice and come sniffing, and perhaps take a few contracts will come our way.
This can only be a very positive outcome for RCE and about time.
Let's hope management can show some ability to get the market to accept how good this can be.
Ann: RCE Establishes Strategic Partnership in South-East Asia, page-17
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.020(3.45%) |
Mkt cap ! $122.3M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 57.5¢ | $23.23K | 39.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3011 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 2101 | 1 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
58.5¢ |
Change
0.020 ( 0.86 %) |
||||
| Open | High | Low | Volume | ||
| 59.0¢ | 59.0¢ | 57.5¢ | 28189 | ||
| Last updated 14.20pm 24/05/2024 ? | |||||
| RCE (ASX) Chart |